ConductScience.org, home

Paper32079263

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.

Batista-Duharte A and 5 others. Biomolecules, 2020. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement. Papers, record 32079263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32079263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.
PubMed
Journal
Biomolecules
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2024-07-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Batista-Duharte AAlexander
2Sendra LLuis
3Herrero MJMaria José
4Téllez-Martínez DDamiana
5Carlos IZIracilda Zeppone
6Aliño SFSalvador Francisco

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
ImmunityMajor topic
Oligonucleotides, AntisenseMajor topic
Animals
Humans
Vaccination
Vaccines

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
FAPESP, Grant Number: 2018/15187-2Fundação de Amparo à Pesquisa do Estado de São PauloInternationalPubMed

Source PubMed

Download CSV of grants

References150

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131836192Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019.Trends Pharmacol Sci2020https://conductscience.org/library/papers/31836192PubMed
230138565T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.Mol Pharm2018https://conductscience.org/library/papers/30138565PubMed
316517711
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
J Immunol2006https://conductscience.org/library/papers/16517711PubMed
49009250Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.Leuk Res1996https://conductscience.org/library/papers/9009250PubMed
55307809The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/5307809PubMed
617172312Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100.Drug Metab Dispos2007https://conductscience.org/library/papers/17172312PubMed
78168141MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice.Cell Immunol1994https://conductscience.org/library/papers/8168141PubMed
816972901Immune resistance orchestrated by the tumor microenvironment.Immunol Rev2006https://conductscience.org/library/papers/16972901PubMed
911365956Fomivirsen approved for CMV retinitis.J Int Assoc Physicians AIDS Care1998https://conductscience.org/library/papers/11365956PubMed
1026283035A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.Eur J Cancer2015https://conductscience.org/library/papers/26283035PubMed
1131195692TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.Int J Mol Sci2019https://conductscience.org/library/papers/31195692PubMed
1224798406Oligonucleotide delivery: a patent review (2010 - 2013).Expert Opin Ther Pat2014https://conductscience.org/library/papers/24798406PubMed
1325666165Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.Adv Drug Deliv Rev2015https://conductscience.org/library/papers/25666165PubMed
146200641Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.J Natl Cancer Inst1984https://conductscience.org/library/papers/6200641PubMed
1522051890Vaccines for the twenty-first century society.Nat Rev Immunol2011https://conductscience.org/library/papers/22051890PubMed
1625994601Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Expert Opin Drug Deliv2015https://conductscience.org/library/papers/25994601PubMed
178476504Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation.Anticancer Drug Des1993https://conductscience.org/library/papers/8476504PubMed
188615886Effect of different chemically modified oligodeoxynucleotides on immune stimulation.Biochem Pharmacol1996https://conductscience.org/library/papers/8615886PubMed
1912489851Antisense oligonucleotides: basic concepts and mechanisms.Mol Cancer Ther2002https://conductscience.org/library/papers/12489851PubMed
2029175113Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal.Pharmacol Res2018https://conductscience.org/library/papers/29175113PubMed

See all 150 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42974492Gene-Specific Antisense Oligonucleotide Therapy Targeting AMA1: A Potential Malaria Treatment.Iran J Parasitol2026https://conductscience.org/library/papers/42974492PubMed
42938726
Comparative Analysis of Inhibition Efficiency of Chimeric Antisense Oligonucleotides with Various Chemical Modifications and Their Application for Exogenous Control of Gene Expression in Escherichia coli.
Antibiotics (Basel)2026https://conductscience.org/library/papers/42938726PubMed
42801377Silencing with precision: In silico strategies for antisense oligonucleotide engineering.Mol Biol Rep2026https://conductscience.org/library/papers/42801377PubMed
42728797Recent Advancements in Drug Delivery Across the Blood-Brain Barrier in Amyotrophic Lateral Sclerosis (ALS).CNS Neurosci Ther2026https://conductscience.org/library/papers/42728797PubMed
42651807Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42651807PubMed
42042810CTLA-4 Antisense Oligonucleotide Contributes to Enhanced Immunogenicity of an Adjuvanted Recombinant Sporothrix spp. Enolase Antigen.Vaccines (Basel)2026https://conductscience.org/library/papers/42042810PubMed
39936282An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.Future Oncol2025https://conductscience.org/library/papers/39936282PubMed
39385255Advances and applications of RNA vaccines in tumor treatment.Mol Cancer2024https://conductscience.org/library/papers/39385255PubMed
39356099Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.Recent Adv Drug Deliv Formul2024https://conductscience.org/library/papers/39356099PubMed
39272802Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside.Cancers (Basel)2024https://conductscience.org/library/papers/39272802PubMed
38422397Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability.Mol Pharm2024https://conductscience.org/library/papers/38422397PubMed
38228506Heterochiral modifications enhance robustness and function of DNA in living human cells.Chembiochem2024https://conductscience.org/library/papers/38228506PubMed
38044945Antisense oligonucleotides: a novel Frontier in pharmacological strategy.Front Pharmacol2023https://conductscience.org/library/papers/38044945PubMed
37099227Combined Application of Antisense Oligomers to Control Transcription Factors of Candida albicans Biofilm Formation.Mycopathologia2023https://conductscience.org/library/papers/37099227PubMed
37006713Analysis of key genes in Mycobacterium ulcerans reveals conserved RNA structural motifs and regions with apparent pressure to remain unstructured.Front Trop Dis2022https://conductscience.org/library/papers/37006713PubMed
36791960A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer.J Adv Res2023https://conductscience.org/library/papers/36791960PubMed
36694567Potential of RH5 Antisense on Plasmodium falciparum Proliferation Abatement.Iran J Parasitol2022https://conductscience.org/library/papers/36694567PubMed
36016952The dark side of Tregs during aging.Front Immunol2022https://conductscience.org/library/papers/36016952PubMed
36015348Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches.Pharmaceutics2022https://conductscience.org/library/papers/36015348PubMed
35628649Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells.Int J Mol Sci2022https://conductscience.org/library/papers/35628649PubMed

See all 21 cited byDownload CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CIITA4261PubTator's text mininghttps://conductscience.org/library/genes/4261NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FOLH12346PubTator's text mininghttps://conductscience.org/library/genes/2346NCBI Gene
HSPB13315PubTator's text mininghttps://conductscience.org/library/genes/3315NCBI Gene
IFIH164135PubTator's text mininghttps://conductscience.org/library/genes/64135NCBI Gene
IFNA83445PubTator's text mininghttps://conductscience.org/library/genes/3445NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32079263

GET https://conductscience.org/api/papers/v1/32079263/references?page=2